Skip to main content

IMS Events Main banner

Nursing and Allied Health Symposium

Nursing and Allied Health Symposium

Type here to filter the list

(NSP-01) The Use of a BCMA-directed Bispecific Antibody to Treat Relapsed Myeloma in a Liver Transplant Patient Receiving Continuous T-cell Immunosuppression and Concurrent Hemodialysis
(NSP-02) Expanding Access to Bispecific Antibodies for Multiple Myeloma: A Multidisciplinary Model to Bridge Academic and Community Care
(NSP-03) Establishing Barriers and Enablers to Nurse-enabled, Subcutaneous Therapy Self-administration Programs for Myeloma Patients - Description of an Implementation Science Study Design
(NSP-04) Enhancing Patient Education and Support in Multiple Myeloma: A Toolkit-based Nursing Intervention
(NSP-05) Bispecific Antibody Therapy in Haematology: A National Cancer Nurse Education Needs Assessment in the United Kingdom
(NSP-06) Supportive Care Needs and Interventions Among Hospitalised Patients with Myeloma Bone Disease: A Single-centre Experience
(NSP-07) Energy and Macronutrient Deficits in Multiple Myeloma: The Hidden Burden Across the Disease Spectrum
(NSP-09) Characterising Critical Disease Burdens: Integration of Primary Care Data and Real-time Patient Monitoring to Transform Multiple Myeloma Care in the UK
(NSP-10) Evaluating a Hybrid Approach to Oncology Pharmacy: A Comparison of Service Delivery Models for Immunomodulatory Drug Management
(NSP-11) Clonal Hematopoiesis in Multiple Myeloma: Current Implications and Future Directions
(NSP-12) Quality Improvement Intervention, the Addition of Lifestyle Medicine Group Sessions in Multiple Myeloma Population
(NSP-13) Strategies for a Successful Transition to Short Infusion Isatuximab for Patients with Multiple Myeloma
(NSP-14) An Examination of Perceived Gaps in Multiple Myeloma Education for Nurses
(NSP-15) Supportive Clinical Care Pathways for Patients Receiving Bispecific Antibody and CAR T-cell Therapy for Multiple Myeloma
(NSP-17) The Power of Partnership: Supporting Patient Adherence to Treatment Through a Unique Collaboration of Healthcare Professional and Patient Organisations
(NSP-18) Describing the Impact on Patients Starting Myeloma Therapy by a Myeloma Care Pharmacist in a Specialized Community Oncology Pharmacy Setting
(NSP-19) Diagnostic Journeys in Myeloma: A Qualitative Exploration of Barriers and Facilitators
(NSP-20) Myeloma Patient Outcome Scale (MyPOS): Cross-cultural Adaptation and Evidence of Validity for Brazilian Population